NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/21/2025
Back to search
Official data from USPTO
COGNITIVE DRUG RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COGNITIVE DRUG RESEARCH
ST13
US500000085749042Class
35, 41, 42
Filing
85749042
Registration
4519989
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
03/18/2025
Trademark type
Word
Nice classes
35, 41, 42
Filing date
10/09/2012
Registration date
04/29/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/21/2025
Last transaction
03/18/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1986-03-00
First use in commerce
1986-03-00
Drawing code
4
Owner type
16
Owner location
BLUE BELL, PA
Examiner
CARLSON, KRISTIN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SIGNANT HEALTH GLOBAL LLC
Bracket Global, LLC
Bracket Global, LLC
Representatives
Anna Kurian Shaw Hogan Lovells US LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services provided to pharmaceutical industry clients involved in Phase III and III trials which measure cognitive function; Business feasibility study planning; Business study data interpretation
Class 41
Training of site staff in the field of pharmaceutical studies
Class 42
Scientific study planning in the field of pharmaceuticals; Rental services relating to data processing equipment and computers for use in studies; Scientific study data analysis in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
56 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/21/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
10/23/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/17/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/29/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/09/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/15/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/15/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/07/2020
E815
TEAS SECTION 8 & 15 RECEIVED
04/29/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/31/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/31/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/29/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/26/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/19/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/22/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2014
PUBO
PUBLISHED FOR OPPOSITION
02/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/09/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
01/07/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/07/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
01/07/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/07/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/03/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2013
GNRT
NON-FINAL ACTION E-MAILED
07/03/2013
CNRT
NON-FINAL ACTION WRITTEN
07/03/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/02/2013
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/24/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/11/2013
ALIE
ASSIGNED TO LIE
06/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/23/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2012
GNRT
NON-FINAL ACTION E-MAILED
11/18/2012
CNRT
NON-FINAL ACTION WRITTEN
11/18/2012
DOCK
ASSIGNED TO EXAMINER
11/09/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2012
NWAP
NEW APPLICATION ENTERED
10/12/2012
Continuous trademark protection
Get notified about every new filing that threatens COGNITIVE DRUG RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.